MBNL1 and prostate adenocarcinoma: To further determine the underlying mechanism of MBNL1-AS1 in PC, we divided 499 tumor samples in the TCGA-PRAD dataset into high and low expression groups, based on the transcriptomic levels of MBNL1-AS1.